For the best user experience please use a browser to proceed.

ILMN - Illumina, Inc price and analysis

Fundamentals:
Basic Info:
  • Market Cap: 72.36B
  • Exchange: NASDAQ
  • Shares Float: 145,520,000
  • Shares Outstanding: 146,000,000
  • Revenue Per Employee:
Advanced Info:
  • ROE ttm: 13.20 %
  • ROA ttm: 4.35 %
  • Beta: 0.947
  • EPS: 4.28
  • Debt Ratio ttm: 0.44
  • Debt / Equity Ratio ttm: 0.78
  • Payout Ratio ttm:
Cash Ratios:
  • Cash Ratio ttm: 3.5
  • Current Ratio ttm: 4.45
  • Quick Ratio ttm: 4.06
Key Ratios:
  • P/E trailing 12 month: 114.85
  • P/E forward: 86.23
  • P/E trailing 12m high: 117.81
  • P/E trailing 12m low: 60.35
  • P/S trailing 12 month: 20.83
  • EV/S trailing 12 month: 19.98
  • P/B trailing 12 month: 14.45
  • PEG ratio: 2.22
Shorts:
  • Shares Short: 2,579,200
  • Shares Short Prev Month: 2,738,700
  • Days to Cover: 4.12
  • Short Percent Float: 1.77 %
  • Short Percent Outstanding: 2.00 %
Ownership:
  • Percent Insiders: 0.26 %
  • Percent Institutions: 92.64 %
Margins:
  • Gross Profit Margin ttm: 68.00 %
  • EBITDA Margin ttm: 22.00 %
  • Operating Margin ttm: 16.00 %
  • Net Income Margin ttm: 18.00 %
Target Prices:
  • Target Price High: 520 USD
  • Target Price Low: 300 USD
  • Target Price Mean: 408.94 USD
  • Number of Analysts: 16
Key Prices:
  • 52 Week High: 508.38
  • 52 Week Low: 260.42
  • 50 Day Moving Average: 464.05
  • 200 Day Moving Average: 423.26
Dividends:
  • Trailing Dividend yld:
  • Forward Dividend yld:
  • Payout Ratio:
  • Ex-Dividend date: None
Current Quarter Estimates:
  • Current Quarter EPS estimate: 1.31 ~ 1.41 (2021-06-30)
  • Current Quarter revenue estimate: 958.59M ~ 1.05B
As of: 2021-07-25
Latest News:
Is Illumina (ILMN) A Smart Long-Term Buy?Yahoo Finance2021-07-22 16:39:07 EDT
The Vaccination of an Entire City in BrazilYahoo Finance2021-07-22 13:01:07 EDT
Is Illumina a Buy?The Motley Fool2021-07-14 07:31:00 EDT
Why Illumina Was Up 17% in JuneThe Motley Fool2021-07-08 16:44:00 EDT
5 Top Stocks for JulyThe Motley Fool2021-07-03 09:00:00 EDT
Is Illumina (ILMN) Outperforming Other Medical Stocks This Year?Zacks Investment Research2021-06-30 12:33:28 EDT
Illumina's (ILMN) NovaSeq Adoption Aids, Margin Woe StaysZacks Investment Research2021-06-22 11:16:51 EDT
Has Illumina Lost Its Shine?The Motley Fool2021-06-12 06:10:00 EDT
Will Illumina Be a Trillion-Dollar Stock by 2035?The Motley Fool2021-06-09 06:47:00 EDT
5 Healthcare Stocks to Buy for Their Game-Changing PotentialInvestorPlace2021-06-08 11:37:52 EDT
7 Beaten-Down Stocks to Buy Right Now for a June ReboundInvestorPlace2021-06-07 12:25:54 EDT
This Biotech Just Made History. Will Its Stock Follow?The Motley Fool2021-06-04 12:55:00 EDT
Illumina (ILMN) Expands NIPT Offering With New CollaborationZacks Investment Research2021-06-01 08:16:04 EDT
Illumina (ILMN) Sequencing & Microarray Sales Hurt by PandemicBusiness Insider2021-02-17 15:55:00 EDT
Is Illumina (ILMN) Stock a Buy For 2021?Insider Monkey2021-02-16 17:48:00 EDT
Illumina Rockets After Topping Q4 EarningsNasdaq2021-02-15 07:58:00 EDT
Why Illumina Stock Is Skyrocketing TodayThe Motley Fool2021-02-12 22:00:00 EDT
Illumina (ILMN) Q4 Earnings Top Estimates, Margins DeclineBusiness Insider2021-02-12 14:17:00 EDT
Illumina Inc (ILMN) Q4 2020 Earnings Call TranscriptThe Motley Fool2021-02-12 03:35:00 EDT
Illumina: 4Q Earnings SnapshotAssociated Press2021-02-11 21:40:00 EDT
A Preview Of Illumina's EarningsBenzinga.com2021-02-10 15:47:00 EDT
Illumina (ILMN) to Report Q4 Earnings: What's in the Offing?Business Insider2021-02-09 14:55:00 EDT
Click to expand the area.
Income Statements:
ILMN - Illumina, Inc Income Statement
Unit: (milllion)2021Q12021Q2
Qtr Revenue953.001093.00
Rev Growth yoy % %
Cost of Revenue323.00329.00
Gross Profit630.00764.00
Gross Profit Mgn66.11 %69.9 %
Research and Development199.00197.00
Selling & Marketing Expense0.000.00
General & Administrative Expense0.000.00
Interest Expense16.0019.00
Operating Expense497.00571.00
Operating Income133.00193.00
Operating Mgn13.96 %17.66 %
Net Income257.00147.00
Net Income Mgn26.97 %13.45 %
Generated by @earningsfly with ❤️
Cashflow Statements:
ILMN - Illumina, Inc Cashflow Statement
Unit: (million)2021Q12021Q2
Operating Cashflows406.00282.00
Financing CashflowsNaNNaN
Investing CashflowsNaNNaN
Total Capital Expenditures-62.00-42.00
Changes In CashNaNNaN
Free Cash flow344.00240.00
Generated by @earningsfly with love ❤️
Balance Sheets:
ILMN - Illumina, Inc Balance Sheet
Unit: (milllion)2018Q22018Q32018Q42019Q12019Q22019Q32019Q42020Q12020Q22020Q32020Q42021Q1
Total Assets5851.006759.006959.007390.006973.007089.007316.007261.007248.007404.007585.008755.00
Intangible Assets1036.001026.001016.001006.00986.00976.00969.00962.001050.001046.001039.001031.00
Goodwill831.00831.00831.00831.00824.00824.00824.00824.00894.00897.00897.00897.00
Current Assets3337.004262.004490.004545.004156.004222.004451.004324.004194.004329.004483.005642.00
Current Cash1344.001346.001144.002270.001943.001815.002042.001991.001770.001761.001810.004433.00
Account Receivables0.00433.00514.00457.00470.00541.00573.00472.00385.00464.00487.00517.00
Inventory362.00374.00386.00412.00420.00417.00359.00384.00435.00415.00372.00364.00
Total Liabilities2594.003256.003201.003405.002641.002650.002703.002626.002685.002704.002891.003833.00
Account Payables149.00156.00184.00137.00139.00143.00149.00130.00135.00156.00192.00178.00
Short Term Debt625.001107.001107.00631.000.000.000.00499.00503.00507.00511.00488.00
Long Term Debt723.003.00890.004.001120.000.000.00652.00659.00666.001184.002160.00
Current Ratio2.742.462.493.666.796.826.694.103.763.883.604.45
Debt Ratio0.230.160.290.090.160.000.000.160.160.160.220.30
Debt/Equity Ratio0.410.320.530.160.260.000.000.250.250.250.360.54
Generated by @earningsfly with ❤️
Latest Posts:
Not available at this time..
Illumina, Inc
(NASDAQ:ILMN)
Illumina, Inc

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequenci...
Founded: 1998
Sector: Healthcare
Industry: Diagnostics & Research
Full Time Employees: 7,825
Next Earnings Date: 2021-08-05
Keywords: Illumina
Summary and stock analysis:
  • Return on equity score:
  • Return on assets score:
  • P/E ratio score:
  • P/B ratio score:
  • P/S ratio score:
  • Revenue growth score:
63K Followers
2371 Followers
Avg: 
 710 review, 165 jobs
Basic Info:
  • Market Cap: 72.36B
  • Exchange: NASDAQ
  • Shares Float: 145,520,000
  • Shares Outstanding: 146,000,000
  • Revenue Per Employee:
Advanced Info:
  • ROE ttm: 13.20 %
  • ROA ttm: 4.35 %
  • Beta: 0.947
  • EPS: 4.28
  • Debt Ratio ttm: 0.44
  • Debt / Equity Ratio ttm: 0.78
  • Payout Ratio ttm:
Cash Ratios:
  • Cash Ratio ttm: 3.5
  • Current Ratio ttm: 4.45
  • Quick Ratio ttm: 4.06
Key Ratios:
  • P/E trailing 12 month: 114.85
  • P/E forward: 86.23
  • P/E trailing 12m high: 117.81
  • P/E trailing 12m low: 60.35
  • P/S trailing 12 month: 20.83
  • EV/S trailing 12 month: 19.98
  • P/B trailing 12 month: 14.45
  • PEG ratio: 2.22
Shorts:
  • Shares Short: 2,579,200
  • Shares Short Prev Month: 2,738,700
  • Days to Cover: 4.12
  • Short Percent Float: 1.77 %
  • Short Percent Outstanding: 2.00 %
Ownership:
  • Percent Insiders: 0.26 %
  • Percent Institutions: 92.64 %
Margins:
  • Gross Profit Margin ttm: 68.00 %
  • EBITDA Margin ttm: 22.00 %
  • Operating Margin ttm: 16.00 %
  • Net Income Margin ttm: 18.00 %
Target Prices:
  • Target Price High: 520 USD
  • Target Price Low: 300 USD
  • Target Price Mean: 408.94 USD
  • Number of Analysts: 16
Key Prices:
  • 52 Week High: 508.38
  • 52 Week Low: 260.42
  • 50 Day Moving Average: 464.05
  • 200 Day Moving Average: 423.26
Dividends:
  • Trailing Dividend yld:
  • Forward Dividend yld:
  • Payout Ratio:
  • Ex-Dividend date: None
Current Quarter Estimates:
  • Current Quarter EPS estimate: 1.31 ~ 1.41 (2021-06-30)
  • Current Quarter revenue estimate: 958.59M ~ 1.05B
As of: 2021-07-25
Click to expand the area.
Analyst Consensus:
ILMN - Illumina, Inc Analyst Opinions
Target high: 520 USD
Target low: 300 USD
Average: 408.94 USD based on 16 analysts as of 2021-07-03

Generated by @earningsfly with ❤️
Analyst Trends:
ILMN - Illumina, Inc Analyst Trends
Target high: 520 USD
Target low: 300 USD
Average: 408.94 USD based on 16 analysts as of 2021-07-03
Generated by @earningsfly with ❤️
Website Ranking Analysis:
ILMN - Illumina, Inc  World Website Ranking Analysis
Generated by @earningsfly with ❤️
Google Trends Analysis:
ILMN - Illumina, Inc Google 5-year Trends Analysis
Keyword: Illumina
Generated by @earningsfly with ❤️
Employees Analysis:
ILMN - Illumina, Inc Employees Analysis
Generated by @earningsfly with ❤️
Institution & Insiders Analysis:
ILMN - Illumina, Inc Ownership Analysis
Generated by @earningsfly with ❤️
Debt & Cash Analysis:
ILMN - Illumina, Inc Cash and Debt Analysis(unit: milllion USD)
Generated by @earningsfly with ❤️
Short Analysis:
ILMN - Illumina, Inc Shorts Analysis
Generated by @earningsfly with 🚀
Margins and Revenue:
ILMN - Illumina, Inc Revenue and Margins
Generated by @earningsfly with 🚀
Income Statement Analysis:
ILMN - Illumina, Inc Income Statement
Unit: (milllion)2021Q12021Q2
Qtr Revenue953.001093.00
Rev Growth yoy % %
Cost of Revenue323.00329.00
Gross Profit630.00764.00
Gross Profit Mgn66.11 %69.9 %
Research and Development199.00197.00
Selling & Marketing Expense0.000.00
General & Administrative Expense0.000.00
Interest Expense16.0019.00
Operating Expense497.00571.00
Operating Income133.00193.00
Operating Mgn13.96 %17.66 %
Net Income257.00147.00
Net Income Mgn26.97 %13.45 %
Generated by @earningsfly with ❤️
Earnings Estimate Analysis:
ILMN - Illumina, Inc EPS Estimates
Current Qtr Estimate (dashed line): 1.35
Generated by @earningsfly with ❤️
Cashflow Analysis:
ILMN - Illumina, Inc Cashflow Statement
Unit: (million)2021Q12021Q2
Operating Cashflows406.00282.00
Financing CashflowsNaNNaN
Investing CashflowsNaNNaN
Total Capital Expenditures-62.00-42.00
Changes In CashNaNNaN
Free Cash flow344.00240.00
Generated by @earningsfly with love ❤️